Vitro Biopharma is extending a 10% discount off their cell and media products on Scientist.com’s Marketplace until March 31, 2024. Request their products here .
About Vitro Biopharma
Aiming to become a leader in the immunology and inflammatory market, Vitro Biopharma is working towards creating transformative medicine that has a positive impact on patients grappling with various diseases. With 30 years of experience, they have efficiently progressed multiple product candidates from drug discovery to clinical trials. Emphasizing timely and cost-effective completion, their established infrastructure and international studies validate efficacy and safety. Vitro Biopharma’s commitment to efficiency, cost-savings, and safety makes them a top choice for cell and media products and related services, contributing significantly to medical science advancement.
Limited-time Discount on Vitro Biopharma’s Cell and Media Products
Vitro Biopharma is extending Scientist.com customers a 10% discount off their cell and media products until March 31, 2024 . Make sure to take advantage of this special offer before the end of Q1 by including Vitro Biopharma in your request here .
Simply create a request for any Vitro Biopharma cell or media products and the discount will be reflected on the SOW.
View select publications that reference Vitro Biopharma’s products below
Pancreatic stellate cancer-associated fibroblasts (CAF08) were plated at 5,000/cm² in a Corning 24 well-plate and maintained in MSC-GRO low serum, complete medium (PC00B5)
Featured Cells and Media
Fabrication of high aspect ratio microfluidic devices for long term in vitro culture of 3D tumor models * Date: 1 January 2023
Vitro Biopharma Product Name CAF08 Pancreatic Cancer-Associated Fibroblasts PC00B5 MSC-GROTM Pancreatic Stellate CAFs PC00B5 Maintenance Medium
Fibroblasts from Distinct Pancreatic Pathologies Exhibit Disease-Specific Properties * Date: May 11, 2020
Vitro Biopharma Product Name SC00A5 Normal Pancreatic Fibroblasts
Cancer-Associated Fibroblasts Produce Netrin-1 to Control Cancer Cell Plasticity * Date: May 14, 2019
Vitro Biopharma Product Name PC00B1 MSC-GROTM VitroPlus III Low Serum Complete Medium CAF05 Colorectal Adenocarcinoma Cancer- CAF05 Associated Fibroblasts
Take the Next Step
Explore Suppliers
Browse trusted partners with relevant expertise
Review Capabilities
Compare services, experience, and past work
Start Your Project
Connect and begin collaborating
.jpg)